Paul Aliu (@PaulAliu2000) profile picture
Switzerland
Joined July 2010
Photo by Paul Aliu (@PaulAliu2000)Photo by Paul Aliu (@PaulAliu2000)
Novartis announces late-breaking data at #ERA24 showing proteinuria reduction in patients with C3G #NovartisNews go.novartis.social/450Dihw

2
1
14
8,791
Great to be back at #IMD for constructive, inspiring and energising dialogues about the state of the world, global economy, businesses as vehicles for change, and making an impact. It’s been 10 years since our executive MBA program, so was awesome catchin…lnkd.in/ektFRBu8
1
3
58
Paul Aliu retweeted
What happens when a patient’s only treatment hope rests with a promising but not yet locally approved therapy? At Novartis, our compassionate use program can provide this lifeline, and we’re further exploring our data to improve early access to medicines. Find out more.
2
4
1
11
4,279
Paul Aliu retweeted
In a first-of-its-kind study using data from our compassionate use program, we discovered vast disparities in requested access linked to national: -level of economic development -availability of regulations -number of clinical trials Discover more:

3
5
11
3,951
Delighted to share our latest publication out today in JAMA Health Forum! Eight-factor regulatory framework proposed to ensure robust #compassionateuse regulations at a country level that would facilitate speedy, ethical, responsi…lnkd.in/eZX4PE-b lnkd.in/egDdbRJM
2
3
173
Novartis has been fighting leprosy for more than 40 years, and we remain committed to leprosy elimination. Track our journey from the inception of multidrug therapy (MDT) to >7 million patients treated worldwide. #BeatNTDs @WHO @ZeroLeprosy @fiocruz @Microsoft @NovartisFDN
3
28
94
Paul Aliu retweeted
We partnered with @NovartisFDN to launch an assessment tool to help decision-makers identify where to best invest resources to enable deployment of #AI solutions in health. Learn about the key takeaways from the initial six countries. https://nitter.cf/t.co/ATmey3ViHE
7
21
In this cohort study, the existence and public availability of CU regulations and local clinical trial activity were positively associated with higher CU request rates. #patientaccess #CompassionateUse @PaulAliu2000 ja.ma/3PmGjPD
1
1